Pub Date : 2023-01-01DOI: 10.5455/jcmr.2023.14.02.10
Lada Ratushnaya, Diana Gabelaia, Sofia Petrova, Tatiana Maksimenko, S. Barinov, Alexander Markov
The article investigates the causes and ways to reduce injuries in age-related patients with multimorbidity. The author points out that Multimorbid people are at significant risk of falls. These results require prioritization of falls as a public health problem with the need to integrate falls into existing geriatric healthcare programs. The combination of multimorbidity and proximal fracture leads to an increase in mortality, which strongly indicates the need for more comprehensive approaches to high-risk patients. Accordingly, there is a need for future research on the care of high-risk patients after a fracture and the study of the relationship between multimorbid clusters and other signaling events in the field of healthcare.
{"title":"Investigation of the Causes and Ways of Reducing Injuries in Age-Related Patients with Multimorbidity","authors":"Lada Ratushnaya, Diana Gabelaia, Sofia Petrova, Tatiana Maksimenko, S. Barinov, Alexander Markov","doi":"10.5455/jcmr.2023.14.02.10","DOIUrl":"https://doi.org/10.5455/jcmr.2023.14.02.10","url":null,"abstract":"The article investigates the causes and ways to reduce injuries in age-related patients with multimorbidity. The author points out that Multimorbid people are at significant risk of falls. These results require prioritization of falls as a public health problem with the need to integrate falls into existing geriatric healthcare programs. The combination of multimorbidity and proximal fracture leads to an increase in mortality, which strongly indicates the need for more comprehensive approaches to high-risk patients. Accordingly, there is a need for future research on the care of high-risk patients after a fracture and the study of the relationship between multimorbid clusters and other signaling events in the field of healthcare.","PeriodicalId":41505,"journal":{"name":"Journal of Complementary Medicine Research","volume":"12 1","pages":""},"PeriodicalIF":0.6,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87910846","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-01-01DOI: 10.5455/jcmr.2023.14.03.12
S. Wajpeyi, Vaishali Kuchewar, Ketki Wajpeyi
Background-Raised total cholesterol, high LDL-C, low HDL-C, and elevated triglycerides are all symptoms of dyslipidemia. It is included in metabolic disorders. It is a major component in causation of atherosclerosis, coronary artery disease and cerebrovascular disease. There is a 1-2 percent rise in the incidence of Coronary Heart Disease for every 1% increase in cholesterol level. As per Ayurveda, it can be considered as a Medadhatu Dushti that is “Medoroga”. Acharya Charaka described drugs having deepana, pachana, medohar, lekhana and strotoshodhaka properties for management of Medoroga. Kutaki (Picrorhiza kurroa Royle ex. Benth) can be used in such conditions due to its lekhana and medohar properties.Various animal research studies conducted on Kutaki proved its antihyperlipidemic and hepatoprotective property. Hence in this case series three patients of dyslipidemia were treated with single dravya Kutaki in tablet form. Case Report-All the three female patients, aged between 40 to 50 years, were treated with Kutaki tablet (500mg) two times a day in the morning and evening (8am-8pm) empty stomach with water for 60 days. After completion of treatment, assessment was done by comparing Serum lipid profile value as with baseline after completion of treatment. Observations and Result -All the three patients showed improvement in lipid values. There was no change in weight or BMI was noted. Conclusion-Hence, it can be concluded that Kutaki is safe and effective in dyslipidemia for normalization of lipid in the blood due to its lekhana, Kapha Medohara (alleviation of vitiated Kapha and Meda) properties.
{"title":"A Case Series of Dyslipidemia Managed with Kutaki (Picrorhiza Kurroa Royle Ex Benth)","authors":"S. Wajpeyi, Vaishali Kuchewar, Ketki Wajpeyi","doi":"10.5455/jcmr.2023.14.03.12","DOIUrl":"https://doi.org/10.5455/jcmr.2023.14.03.12","url":null,"abstract":"Background-Raised total cholesterol, high LDL-C, low HDL-C, and elevated triglycerides are all symptoms of dyslipidemia. It is included in metabolic disorders. It is a major component in causation of atherosclerosis, coronary artery disease and cerebrovascular disease. There is a 1-2 percent rise in the incidence of Coronary Heart Disease for every 1% increase in cholesterol level. As per Ayurveda, it can be considered as a Medadhatu Dushti that is “Medoroga”. Acharya Charaka described drugs having deepana, pachana, medohar, lekhana and strotoshodhaka properties for management of Medoroga. Kutaki (Picrorhiza kurroa Royle ex. Benth) can be used in such conditions due to its lekhana and medohar properties.Various animal research studies conducted on Kutaki proved its antihyperlipidemic and hepatoprotective property. Hence in this case series three patients of dyslipidemia were treated with single dravya Kutaki in tablet form. Case Report-All the three female patients, aged between 40 to 50 years, were treated with Kutaki tablet (500mg) two times a day in the morning and evening (8am-8pm) empty stomach with water for 60 days. After completion of treatment, assessment was done by comparing Serum lipid profile value as with baseline after completion of treatment. Observations and Result -All the three patients showed improvement in lipid values. There was no change in weight or BMI was noted. Conclusion-Hence, it can be concluded that Kutaki is safe and effective in dyslipidemia for normalization of lipid in the blood due to its lekhana, Kapha Medohara (alleviation of vitiated Kapha and Meda) properties.","PeriodicalId":41505,"journal":{"name":"Journal of Complementary Medicine Research","volume":"138 1","pages":""},"PeriodicalIF":0.6,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86276103","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-01-01DOI: 10.5455/jcmr.2023.14.02.04
A. Padmapriya, R. Priyadharshini, Palati Sindhuja
Wound healing is a complicated process in which the skin or the afflicted organ heals itself after an injury. In numerous animal models, scientific validation for the use of most of these botanical parts and species in the management and treatment of prenatal and postnatal complications has been reported. As a result of its bioactivity, biocompatibility, osteoconductivity, structural and chemical similarity to bone and teeth, host tissue bonding ability, and absence of inflammatory characteristic, it has the capacity to regenerate tissue. Our study aimed to identify the wound healing property of Tridax procumbens in Clinical models. In this study we have identified the various phytochemical activities such as cytotoxic effect, anti inflammatory, anti microbial, free radical scavenging and wound healing activity of tridax procumbens. It was found that Tridax procumbens accelerated the healing process by enhancing the epithelial regeneration of wounds. The potent activity of the herbal formulation can be attributed to the phyto-constituents present in the formulation enhance the wound healing effect. Additional research is necessary to understand both the target-based mechanism of action and other pharmacological effects
{"title":"Evaluation of Wound Healing Potential of ethanolic extract of Tridax Procumbens L. in clinical models","authors":"A. Padmapriya, R. Priyadharshini, Palati Sindhuja","doi":"10.5455/jcmr.2023.14.02.04","DOIUrl":"https://doi.org/10.5455/jcmr.2023.14.02.04","url":null,"abstract":"Wound healing is a complicated process in which the skin or the afflicted organ heals itself after an injury. In numerous animal models, scientific validation for the use of most of these botanical parts and species in the management and treatment of prenatal and postnatal complications has been reported. As a result of its bioactivity, biocompatibility, osteoconductivity, structural and chemical similarity to bone and teeth, host tissue bonding ability, and absence of inflammatory characteristic, it has the capacity to regenerate tissue. Our study aimed to identify the wound healing property of Tridax procumbens in Clinical models. In this study we have identified the various phytochemical activities such as cytotoxic effect, anti inflammatory, anti microbial, free radical scavenging and wound healing activity of tridax procumbens. It was found that Tridax procumbens accelerated the healing process by enhancing the epithelial regeneration of wounds. The potent activity of the herbal formulation can be attributed to the phyto-constituents present in the formulation enhance the wound healing effect. Additional research is necessary to understand both the target-based mechanism of action and other pharmacological effects","PeriodicalId":41505,"journal":{"name":"Journal of Complementary Medicine Research","volume":"67 1","pages":""},"PeriodicalIF":0.6,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"90595182","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-01-01DOI: 10.5455/jcmr.2023.14.03.13
S. Priyadarshini, D. Basu, R. Kar, T. Dutta
Aims Of the Study: To study the type of light chain restriction and correlate it with the morphological parameters, proliferation index, angiogenesis and clinical parameters. Materials And Methods: The study includes 46 cases of myeloma diagnosed over the period of five years. The histomorphological features like plasma cell morphology, percentage of plasma cells and pattern of infiltration were studied. Immunohistochemistry for kappa and lambda light chains was done. Angiogenesis was assessed by calculating the microvessel density (MVD) using anti CD34 immunohistochemistry. Proliferation was assessed immunohistochemically using Ki67 by comparing with anti CD38 which was used to highlight the plasma cells. Results: The cases with kappa light chain restriction had significantly less of poorly differentiated morphology (7.4% vs 36.8%; p=0.02) and diffuse pattern of infiltration (22% vs 63%; p=0.01) compared to lambda. The kappa group also had lower MVD (9.9 vs 16.5; p=0.02) and proliferation index (4.7 vs 94; p=0.04) compared to the lambda. Conclusion: Therefore, the type of light chain restriction is also a prognostic factor in plasma cell myeloma.
研究目的:研究轻链限制类型及其与形态学参数、增殖指数、血管生成及临床参数的关系。材料和方法:该研究包括在五年内诊断的46例骨髓瘤病例。研究了浆细胞形态、浆细胞百分比、浸润方式等组织形态学特征。对kappa和lambda轻链进行免疫组化处理。利用抗CD34免疫组化技术计算微血管密度(MVD)来评估血管生成。用免疫组织化学方法Ki67检测浆细胞的增殖情况，并与抗CD38进行比较。结果:kappa轻链限制组低分化形态发生率显著降低(7.4% vs 36.8%;P =0.02)和弥漫性浸润模式(22% vs 63%;P =0.01)。kappa组的MVD也较低(9.9 vs 16.5;P =0.02)和增殖指数(4.7 vs 94;P =0.04)。结论:轻链限制类型也是影响浆细胞骨髓瘤预后的因素之一。
{"title":"Comparison Of Histomorphology, Angiogenesis and Proliferation in Kappa and Lambda Restricted Plasma Cell Myelomas with Its \u0000Effect on Prognosis","authors":"S. Priyadarshini, D. Basu, R. Kar, T. Dutta","doi":"10.5455/jcmr.2023.14.03.13","DOIUrl":"https://doi.org/10.5455/jcmr.2023.14.03.13","url":null,"abstract":"Aims Of the Study: To study the type of light chain restriction and correlate it with the morphological parameters, proliferation index, angiogenesis and clinical parameters. Materials And Methods: The study includes 46 cases of myeloma diagnosed over the period of five years. The histomorphological features like plasma cell morphology, percentage of plasma cells and pattern of infiltration were studied. Immunohistochemistry for kappa and lambda light chains was done. Angiogenesis was assessed by calculating the microvessel density (MVD) using anti CD34 immunohistochemistry. Proliferation was assessed immunohistochemically using Ki67 by comparing with anti CD38 which was used to highlight the plasma cells. Results: The cases with kappa light chain restriction had significantly less of poorly differentiated morphology (7.4% vs 36.8%; p=0.02) and diffuse pattern of infiltration (22% vs 63%; p=0.01) compared to lambda. The kappa group also had lower MVD (9.9 vs 16.5; p=0.02) and proliferation index (4.7 vs 94; p=0.04) compared to the lambda. Conclusion: Therefore, the type of light chain restriction is also a prognostic factor in plasma cell myeloma.","PeriodicalId":41505,"journal":{"name":"Journal of Complementary Medicine Research","volume":"148 1","pages":""},"PeriodicalIF":0.6,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"79205333","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-01-01DOI: 10.5455/jcmr.2023.14.02.08
Didem mehmet, lknur rkbir, Bahar nba, I. l
Aim and Background: Identifying the learning styles is important to ensure full and effective learning in nursing students studying in a field that requires clinical practice and experience. For this aim, determined the dominant learning styles of nursing students and to evaluate the affecting factors using the decision tree method. Methods: The study was conducted with 421 students studying nursing at a university in Turkey. “CART”, “CHAID” and “QUEST” decision tree algorithms were used to evaluate the factors affecting learning styles. Results: Of the students, 48% had visual, 36% tactile, 9% kinesthetic, and 7% auditory learning styles. In the decision tree model, living place and university entrance scores were found to have statistically significant effects on learning styles (p<0.05). Conclusion: This study determined that nursing students predominantly had the visual learning style and that the living place was the variable with the most pronounced effect on learning style.
{"title":"Determining Nursing Students’ Dominant Learning Styles and Evaluating the Affecting Factors Using Decision Tree Method","authors":"Didem mehmet, lknur rkbir, Bahar nba, I. l","doi":"10.5455/jcmr.2023.14.02.08","DOIUrl":"https://doi.org/10.5455/jcmr.2023.14.02.08","url":null,"abstract":"Aim and Background: Identifying the learning styles is important to ensure full and effective learning in nursing students studying in a field that requires clinical practice and experience. For this aim, determined the dominant learning styles of nursing students and to evaluate the affecting factors using the decision tree method. Methods: The study was conducted with 421 students studying nursing at a university in Turkey. “CART”, “CHAID” and “QUEST” decision tree algorithms were used to evaluate the factors affecting learning styles. Results: Of the students, 48% had visual, 36% tactile, 9% kinesthetic, and 7% auditory learning styles. In the decision tree model, living place and university entrance scores were found to have statistically significant effects on learning styles (p<0.05). Conclusion: This study determined that nursing students predominantly had the visual learning style and that the living place was the variable with the most pronounced effect on learning style.","PeriodicalId":41505,"journal":{"name":"Journal of Complementary Medicine Research","volume":"34 1","pages":""},"PeriodicalIF":0.6,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85662134","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-01-01DOI: 10.5455/jcmr.2023.14.03.35
Abdulrahman Alardan, H. Alkhudairi, Ghanim Almotiri, Saad Shamsy
Introduction: Cancer-related fatigue (CRF) is a substantial medical issue that affects patients at all phases of their therapy and escalates with advanced cancer. To gather indications for the use of methylphenidate is objective of the study for the treatment of CRF, as well as to analyse the efficiency and safety of methylphenidate for the treatment of CRF so that we can tailor methylphenidate treatment to response patient only. Methods: To conduct the review of RCTs Systematic Reviews (PRISMA) statement was ideally chosen for Reporting Items. From inception through the first week of October 2021, A systematic search of the electronic databases PubMed, Embase, PSYCHInfo, and the Cochrane Library was done without any language restrictions. This helped to find all RCTs about the use of methylphenidate in patients with CRF. Search terms used were: methylphenidate, dexmethylphenidate, Ritalin, cancer, tumor, carcinoma, neoplasm, fatigue, asthenia, tiredness, CRF, and RCT. We also looked over a few journals' references to find more theoretically related papers. Results: A total of 267 citations were screened; among them, after a preliminary review 231 were excluded. 36 full-text articles assessed for eligibility; among them, 10 articles were met the inclusion criteria where all the selected articles were of good quality. Among 10 studies, 5 were identified in mixed tumor, 2 in prostate cancer, 1 in GI cancer, 1 in advanced cancer and 1 in Gynaecologic cancer. The characteristics of the studies changed broadly in terms of the treatment term and the population studied. Conclusion: To summarize up this study, cancer-related weakness could be critical clinical issue for cancer patients. Our findings suggest that methylphenidate may be useful in the treatment of CRF, but the evidence is inconclusive and has to be confirmed in a bigger study. All of the investigations, however, had tiny sample sizes. This counsel must be respected as provisional and temporary within the absence of considerable information from a single, expansive, well conducted randomized controlled trial. To support and propose new research topics and interventions, more study into biological factors affecting weariness is required.
{"title":"Role of methylphenidate in cancer-related fatigue: A Systemic Review","authors":"Abdulrahman Alardan, H. Alkhudairi, Ghanim Almotiri, Saad Shamsy","doi":"10.5455/jcmr.2023.14.03.35","DOIUrl":"https://doi.org/10.5455/jcmr.2023.14.03.35","url":null,"abstract":"Introduction: Cancer-related fatigue (CRF) is a substantial medical issue that affects patients at all phases of their therapy and escalates with advanced cancer. To gather indications for the use of methylphenidate is objective of the study for the treatment of CRF, as well as to analyse the efficiency and safety of methylphenidate for the treatment of CRF so that we can tailor methylphenidate treatment to response patient only. Methods: To conduct the review of RCTs Systematic Reviews (PRISMA) statement was ideally chosen for Reporting Items. From inception through the first week of October 2021, A systematic search of the electronic databases PubMed, Embase, PSYCHInfo, and the Cochrane Library was done without any language restrictions. This helped to find all RCTs about the use of methylphenidate in patients with CRF. Search terms used were: methylphenidate, dexmethylphenidate, Ritalin, cancer, tumor, carcinoma, neoplasm, fatigue, asthenia, tiredness, CRF, and RCT. We also looked over a few journals' references to find more theoretically related papers. Results: A total of 267 citations were screened; among them, after a preliminary review 231 were excluded. 36 full-text articles assessed for eligibility; among them, 10 articles were met the inclusion criteria where all the selected articles were of good quality. Among 10 studies, 5 were identified in mixed tumor, 2 in prostate cancer, 1 in GI cancer, 1 in advanced cancer and 1 in Gynaecologic cancer. The characteristics of the studies changed broadly in terms of the treatment term and the population studied. Conclusion: To summarize up this study, cancer-related weakness could be critical clinical issue for cancer patients. Our findings suggest that methylphenidate may be useful in the treatment of CRF, but the evidence is inconclusive and has to be confirmed in a bigger study. All of the investigations, however, had tiny sample sizes. This counsel must be respected as provisional and temporary within the absence of considerable information from a single, expansive, well conducted randomized controlled trial. To support and propose new research topics and interventions, more study into biological factors affecting weariness is required.","PeriodicalId":41505,"journal":{"name":"Journal of Complementary Medicine Research","volume":"86 1","pages":""},"PeriodicalIF":0.6,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"80719023","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-01-01DOI: 10.5455/jcmr.2023.14.02.07
S. Nadaf, Jamaleldin Sabahi, A. Lawati, Almandhar Mamari, F. Kindi, Abdulaziz Mawal, Houda Ruqaishi, Ahmed Ghafri, A. Farsi, N. Saady
Background: Several plant extracts are now prescribed as nutraceuticals for human ailments in developed countries like China, France, Germany, the UK, USA including Oman. The objective of this study was to investigate on morphological characteristics, chlorophyll content of leaves, leaf chlorophyll, essential oil, and its chemical compounds to examine the possibility of isolating its incipient chemical compounds commercially in wild Salvia macilenta Boiss. Methods: Leaf samples of ten randomly selected Salvia plants were collected from two diversified wadi habitats. Edaphic features of the sites were recorded and their chemical contents, determined. Morphological characters were measured and chlorophyll contents, recorded. The essential oil (EO) was extracted and analyzed for chemical compounds. The data were statistically analyzed. Results: Al-Khoud plants had higher expressivity in all the morphological characters and chlorophyll contents than those of Halban. The EO yields of Salvia macilenta were 0.06 % (v/w) and 0.088 % (v/w) for the plant samples of Al-Khoud and Halban, respectively. The values of commonly occurring chemical contents of plants of two sites were found statistically similar (p<0.05). The top ten chemical compounds of plants contributed over 75% of the total and were common with seven chemical compounds. Of the ten top chemical compounds, alpha-Pinene, beta- Eudesmol, and Nerolidol contributed the highest in the same range from 61.13% (Al-Khoud) to 62.95% (Halban). These three compounds have the potential for use in both the pharmaceutical and perfumery industries. Conclusion: Wild Salvia plants can be exploited with Good Agriculture Practices for their medicinal and aromatic application.
{"title":"Exploring the Potential of Wild Salvia macilenta Boiss. of Oman as Nutraceuticals","authors":"S. Nadaf, Jamaleldin Sabahi, A. Lawati, Almandhar Mamari, F. Kindi, Abdulaziz Mawal, Houda Ruqaishi, Ahmed Ghafri, A. Farsi, N. Saady","doi":"10.5455/jcmr.2023.14.02.07","DOIUrl":"https://doi.org/10.5455/jcmr.2023.14.02.07","url":null,"abstract":"Background: Several plant extracts are now prescribed as nutraceuticals for human ailments in developed countries like China, France, Germany, the UK, USA including Oman. The objective of this study was to investigate on morphological characteristics, chlorophyll content of leaves, leaf chlorophyll, essential oil, and its chemical compounds to examine the possibility of isolating its incipient chemical compounds commercially in wild Salvia macilenta Boiss. Methods: Leaf samples of ten randomly selected Salvia plants were collected from two diversified wadi habitats. Edaphic features of the sites were recorded and their chemical contents, determined. Morphological characters were measured and chlorophyll contents, recorded. The essential oil (EO) was extracted and analyzed for chemical compounds. The data were statistically analyzed. Results: Al-Khoud plants had higher expressivity in all the morphological characters and chlorophyll contents than those of Halban. The EO yields of Salvia macilenta were 0.06 % (v/w) and 0.088 % (v/w) for the plant samples of Al-Khoud and Halban, respectively. The values of commonly occurring chemical contents of plants of two sites were found statistically similar (p<0.05). The top ten chemical compounds of plants contributed over 75% of the total and were common with seven chemical compounds. Of the ten top chemical compounds, alpha-Pinene, beta- Eudesmol, and Nerolidol contributed the highest in the same range from 61.13% (Al-Khoud) to 62.95% (Halban). These three compounds have the potential for use in both the pharmaceutical and perfumery industries. Conclusion: Wild Salvia plants can be exploited with Good Agriculture Practices for their medicinal and aromatic application.","PeriodicalId":41505,"journal":{"name":"Journal of Complementary Medicine Research","volume":"32 1","pages":""},"PeriodicalIF":0.6,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"91073837","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-01-01DOI: 10.5455/jcmr.2023.14.01.16
I. Elisha, J. Gotep, M. Makoshi, J. Usman, Blessing Shok, K. Oyebade, Z. Muhammad, Itodo Akogwu, K. Tondo, Hong Joseph, Edirin Akpojosevbe, B. Yakubu, Maryam Division, N. Vom, Plateau Stat
Euphorbia hirta L.. is a common herb with global spread. Different parts of E. hirta are used in traditional medicine for the treatment of a variety of human and animal conditions, such as skin diseases, inflammation, digestive and respiratory disorders. This bibliometric study aimed to provide a panoramic view of the publication landscape in the last thirty years of Euphorbia hirta research. VOSviewer was used to analyze 603 documents retrieved from Scopus database during the period, 1992 to 2021. Dominant research themes in the last thirty years were centred on the application of crude extracts or isolated compounds from E. hirta against diabetes, oxidative stress, inflammation, tuberculosis, snake bite, gastro-intestinal disorders, respiratory infections, skin pathologies, bacterial, fungal and viral infections. Current paradigm shift in E. hirta research are targeted at improving the efficacy of phytomolecules against resistant bacterial pathogens and cancer cells via green synthesis of nanoparticles and the application of in silico technologies in predicting the activities of nano-phytomolecules against SARS-CoV-2 and the dengue virus. This study recommends further research in the determination of the bioavailability of molecules in in vivo models. Researchers should carry out more preclinical investigations with the aim of establishing the pharmacokinetic and pharmacodynamic properties of phytocompounds instead of relying solely on in silico predictions.
{"title":"Trends in Euphorbia hirta Research: A 30-year Bibliometric Appraisal of the Present Realities","authors":"I. Elisha, J. Gotep, M. Makoshi, J. Usman, Blessing Shok, K. Oyebade, Z. Muhammad, Itodo Akogwu, K. Tondo, Hong Joseph, Edirin Akpojosevbe, B. Yakubu, Maryam Division, N. Vom, Plateau Stat","doi":"10.5455/jcmr.2023.14.01.16","DOIUrl":"https://doi.org/10.5455/jcmr.2023.14.01.16","url":null,"abstract":"Euphorbia hirta L.. is a common herb with global spread. Different parts of E. hirta are used in traditional medicine for the treatment of a variety of human and animal conditions, such as skin diseases, inflammation, digestive and respiratory disorders. This bibliometric study aimed to provide a panoramic view of the publication landscape in the last thirty years of Euphorbia hirta research. VOSviewer was used to analyze 603 documents retrieved from Scopus database during the period, 1992 to 2021. Dominant research themes in the last thirty years were centred on the application of crude extracts or isolated compounds from E. hirta against diabetes, oxidative stress, inflammation, tuberculosis, snake bite, gastro-intestinal disorders, respiratory infections, skin pathologies, bacterial, fungal and viral infections. Current paradigm shift in E. hirta research are targeted at improving the efficacy of phytomolecules against resistant bacterial pathogens and cancer cells via green synthesis of nanoparticles and the application of in silico technologies in predicting the activities of nano-phytomolecules against SARS-CoV-2 and the dengue virus. This study recommends further research in the determination of the bioavailability of molecules in in vivo models. Researchers should carry out more preclinical investigations with the aim of establishing the pharmacokinetic and pharmacodynamic properties of phytocompounds instead of relying solely on in silico predictions.","PeriodicalId":41505,"journal":{"name":"Journal of Complementary Medicine Research","volume":"13 1","pages":""},"PeriodicalIF":0.6,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84820115","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-01-01DOI: 10.5455/jcmr.2023.14.03.25
Abdullah Demirli, Emre Yamaner, Eda elik, A. Moghanlou
{"title":"Review Of Physiological Responses to Eight-Week Basketball Trainings","authors":"Abdullah Demirli, Emre Yamaner, Eda elik, A. Moghanlou","doi":"10.5455/jcmr.2023.14.03.25","DOIUrl":"https://doi.org/10.5455/jcmr.2023.14.03.25","url":null,"abstract":"<jats:p />","PeriodicalId":41505,"journal":{"name":"Journal of Complementary Medicine Research","volume":"29 1","pages":""},"PeriodicalIF":0.6,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"81888852","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-01-01DOI: 10.5455/jcmr.2023.14.01.14
S. Sivanantham, D. M, A. Velmurugan, Dr. T. Deepa, Akshaya V
Human are vulnerable to the terrible disease named cancer, which is a major factor in the high mortality rate. There are currently lesser DLTs (Deep learning techniques) or MLTs (machine learning techniques) for identifying cancer, despite advances in cancer treatment approaches. The proposed work performs a comparative study which compares the some significant DLTs like RFs (Random Forests), LSTMs (Long Short Term Memories), CNNs (Convolutional Neural Networks) and BPNNs (Back Propagation Neural Networks). These techniques are used here in this work for classification problem. The techniques are made to classify the medical records into benignand cancerous. Three pathological datasets are used to evaluate the above said techniques. CNNs provide the best performance of 0.97 accuracy and it is even good at its values of precisions, recalls and F1 scores.
{"title":"Application of Convolutional Neural Network for Cancer Disease Diagnosis – A Deep Learning based Approach","authors":"S. Sivanantham, D. M, A. Velmurugan, Dr. T. Deepa, Akshaya V","doi":"10.5455/jcmr.2023.14.01.14","DOIUrl":"https://doi.org/10.5455/jcmr.2023.14.01.14","url":null,"abstract":"Human are vulnerable to the terrible disease named cancer, which is a major factor in the high mortality rate. There are currently lesser DLTs (Deep learning techniques) or MLTs (machine learning techniques) for identifying cancer, despite advances in cancer treatment approaches. The proposed work performs a comparative study which compares the some significant DLTs like RFs (Random Forests), LSTMs (Long Short Term Memories), CNNs (Convolutional Neural Networks) and BPNNs (Back Propagation Neural Networks). These techniques are used here in this work for classification problem. The techniques are made to classify the medical records into benignand cancerous. Three pathological datasets are used to evaluate the above said techniques. CNNs provide the best performance of 0.97 accuracy and it is even good at its values of precisions, recalls and F1 scores.","PeriodicalId":41505,"journal":{"name":"Journal of Complementary Medicine Research","volume":"40 1","pages":""},"PeriodicalIF":0.6,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86473163","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：